1 EXHIBIT 10.57 CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.800(b)(4), 200.83 and 240.24b-2 [GENE LOGIC LETTERHEAD] September 28, 1999 Mr. K. Kiyose Japan Tobacco Inc. Pharmaceutical Division JT Building 2-1, Toranomon 2-chome...Gene Logic Inc • November 15th, 1999 • Services-commercial physical & biological research
Company FiledNovember 15th, 1999 Industry
AGREEMENTGene Logic Inc • November 15th, 1999 • Services-commercial physical & biological research • Maryland
Company FiledNovember 15th, 1999 Industry Jurisdiction